Compared with nonusers, those on a GLP-1 receptor agonist had fewer thromboembolic events and higher survival.

Women are twice as likely as men to receive replacement and have higher rates of recurrent MR, but survival is similar.

For patients undergoing transcatheter tricuspid valve replacement (TTVR), major adverse events naturally impact both hospital ...

The condition is a main determinant of CV risk and a major contributor to premature mortality, Chiadi Ndumele says.

The combination of all of this just told us that it was time that we needed to provide the international community with ...

Race and ethnicity modified the associations, with the hypotension connection considered to be hypothesis-generating.

While operators from different camps have disparate views and expectations, most agree the time is right for a definitive ...

When pain relief is needed, the agents lessen bleeding risks compared with nonselective NSAIDs, observational data suggest.

The trend is amplified by an aging population that becomes increasingly vulnerable to CVD tied to rising temperatures.

May is a busy but invigorating season for the TCTMD team—in-person connections abound and the stream of data never stops. The ...

The results support the potential to change the trajectory of kidney function decline and extend life expectancy.

Compared with clopidogrel, the drug comes with better efficacy and less risk of major bleeding than ticagrelor.